Cervical cancer drug to be subsidised

Cervical cancer patients will now have cheaper access to a life saving drug that previously cost $55,000 per course of treatment.

Minister for Health Susan Ley

File image of Minister for Health Sussan Ley. Source: AAP

Cervical cancer sufferers will now get taxpayer subsidised access to a life-saving drug that was previously out of reach for many at $55,000 per course of treatment.

Health Minister Sussan Ley has opted to allocate $60 million to list Bevacizumab (Avastin) on the Pharmaceutical Benefits Scheme for cases of cervical cancer where surgery and radiation is not a viable treatment.

The move is expected to save the lives of more than 200 women, who will now pay just $6.20 per script if they're a concessional patient or $38.30 if they're a general patient.


Share
1 min read

Published

Source: AAP

Tags

Share this with family and friends


Get SBS News daily and direct to your Inbox

Sign up now for the latest news from Australia and around the world direct to your inbox.

By subscribing, you agree to SBS’s terms of service and privacy policy including receiving email updates from SBS.

Download our apps
SBS News
SBS Audio
SBS On Demand

Listen to our podcasts
An overview of the day's top stories from SBS News
Interviews and feature reports from SBS News
Your daily ten minute finance and business news wrap with SBS Finance Editor Ricardo Gonçalves.
A daily five minute news wrap for English learners and people with disability
Get the latest with our News podcasts on your favourite podcast apps.

Watch on SBS
SBS World News

SBS World News

Take a global view with Australia's most comprehensive world news service
Watch the latest news videos from Australia and across the world